Cargando...

Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma

BACKGROUND: The need for new therapies for cholangiocarcinoma is highlighted by their poor prognosis and refractoriness to chemotherapy. Increased production of Interleukin-6 promotes cholangiocarcinoma growth and contributes to chemoresistance by activating cell survival mechanisms. We sought to id...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Braconi, Chiara, Swenson, Erica, Kogure, Takayuki, Huang, Nianyuan, Patel, Tushar
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2010
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002961/
https://ncbi.nlm.nih.gov/pubmed/21179572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0015195
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!